Vaccine maker Changsheng to be delisted

Action against firm for falsifying production and inspection records

ST Changsheng, a vaccine maker suspected of market malpractice, said it has been asked to delist by the Shenzhen Stock Exchange on Tuesday.

Analysts said the development is a sign that the nation's securities regulator is committed to tight supervision of underperforming listed companies and to strict implementation of delisting rules.